Status:
NOT_YET_RECRUITING
Clinical Value of DWI-ADC Matching in the Short-term Prognosis of Wilson's Disease
Lead Sponsor:
Hospital Affiliated to the Institute of Neurology, Anhui University of Chinese Medicine
Conditions:
Hepatolenticular Degeneration; Wilson
Eligibility:
All Genders
Brief Summary
In earlier studies, it was found that patients of Wilson disease with new diagnosed who only has neurological symptoms often had DWI hyper-intensity in brain MRI, which was more common in putamen and ...
Eligibility Criteria
Inclusion
- Patients had been previously diagnosed with WD who both had DWI hyper-intensity and ADC hyper-intensity or hypo-intensity at the same time；
- Patients who accept de-copper treatment in hospitalization for 4 weeks or more.
Exclusion
- Patients who only with liver injury;
- Severe complications;
- Combined with other diseases.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06196931
Start Date
January 1 2024
End Date
December 31 2026
Last Update
January 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The affiliated hospital of Institute of Neurology in Anhui University of Chinese Medicine
Hefei, Anhui, China, 230001